BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1080678)

  • 1. [Willebrand's disease and platelet adhesiveness in the presence of ristocetine].
    Alexander P; Streiff F; Stoltz JF; Andre E
    Blut; 1975 Aug; 31(2):87-94. PubMed ID: 1080678
    [No Abstract]   [Full Text] [Related]  

  • 2. Von Willebrand's disease.
    Pitney WR
    Aust N Z J Med; 1973 Jun; 3(3):305-6. PubMed ID: 4542360
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Clotting factors in von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Bintadish P; Mannucci PM
    Lancet; 1974 Jul; 2(7872):105-6. PubMed ID: 4136883
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larieu MJ
    Lancet; 1974 Mar; 1(7856):512-3. PubMed ID: 4131919
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Varieties of von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    Lancet; 1974 Jul; 2(7874):222-3. PubMed ID: 4135642
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet responses to ristocetin in von Willebrand's disease.
    Sanderson JH; Burn AM; Cooke S
    Scand J Haematol; 1974; 12(4):249-55. PubMed ID: 4545782
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Bleeding in von Willebrand's disease.
    Ratnoff OD; Saito H
    N Engl J Med; 1974 May; 290(19):1089. PubMed ID: 4545000
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease.
    Takahashi H
    Thromb Res; 1980 Sep; 19(6):857-67. PubMed ID: 6781099
    [No Abstract]   [Full Text] [Related]  

  • 16. Von Willebrand's disease type B: a newly defined bleeding diathesis.
    Firkin B; Firkin F; Stott L
    Aust N Z J Med; 1973 Jun; 3(3):225-9. PubMed ID: 4125893
    [No Abstract]   [Full Text] [Related]  

  • 17. Inherited variants of factor-VIII-related protein in von Willebrand's disease.
    Peake IR; Bloom AL; Giddings JC
    N Engl J Med; 1974 Jul; 291(3):113-7. PubMed ID: 4546110
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.